2026 Insurance Labelling 
The Checkup by Singlecare
AUGUST 1, 2024
With or without insurance or Medicare, there are additional ways to reduce out-of-pocket expenses for Trintellix. Without private insurance or Medicare prescription drug coverage, the cost of Trintellix varies depending on the pharmacy and location. In some cases, insurance plans may also implement step therapy protocols.
The Checkup by Singlecare
FEBRUARY 10, 2025
No generic version of Januvia is available in the United States, but this could change in 2026 when the main patent expires. The first patent, covering the dihydrogen phosphate salt of sitagliptin, expires on November 24, 2026. Polycystic ovary syndrome (PCOS) Januvia can also be prescribed off-label to treat PCOS.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Checkup by Singlecare
MARCH 21, 2024
These findings have spurred further research, with ongoing clinical trials set to conclude in October 2026. Always consult a healthcare provider for the appropriate dosage, and closely follow their instructions for maximum safety and effectiveness, especially if you’re using the medication off-label for a condition other than diabetes.
Pharmaceutical Technology
JULY 7, 2025
The positive results from the KONFIDENT trial were further supported by findings from the real-world KONFIDENT-S open-label extension study. KalVista will receive an upfront payment of $11m, with an additional $11m contingent upon achieving a regulatory milestone anticipated by early 2026. Sign up for our daily news round-up!
Pharmaceutical Technology
JUNE 16, 2025
At the 2025 Congress of the European Hematology Association (EHA 2025), held from 12 June 12 to 15 June in Milan, Italy, preliminary dose-escalation and optimisation results from the global, multicentre, open-label, single-arm Phase I/II SYRUS clinical trial (NCT06137118) were presented on the second day. billion for Blincyto.
The Checkup by Singlecare
APRIL 22, 2025
However, Trintellixs patent expires in June 2026, and a generic may emerge after that. That might differ slightly in the US, but even when the Trintellix patent ends in 2026, its generic probably wont debut until 2027 or later. Until then, there are other ways to save on Trintellix , whether or not you have insurance coverage.
Pharmaceutical Technology
JUNE 13, 2025
By GlobalData Learn more about Strategic Intelligence Moderna said it plans to have mRESVIA available for both both younger adults and older adults in the US in time for the 2025-2026 respiratory virus season. This usually begins around November and peaks in the mid-Winter months. Give your business an edge with our leading industry insights.
Expert insights. Personalized for you.
98 
Let's personalize your content